Canagliflozin alleviates high glucose-induced peritoneal fibrosis via HIF-1α inhibition

The cardioprotective effects of sodium-glucose cotransporter type 2 (SGLT2) inhibitors have been demonstrated in many studies. However, their benefits for end-stage kidney disease patients, particularly those on peritoneal dialysis, remain unclear. SGLT2 inhibition has shown peritoneal protective ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jian, Lv, Xin, A-Ni-Wan, A-Shan-Jiang, Tian, Sha-Sha, Wang, Jun-Mei, Liu, Hong-Yan, Fan, Xiao-Guang, Zhou, Sai-Jun, Yu, Pei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213900/
https://www.ncbi.nlm.nih.gov/pubmed/37251320
http://dx.doi.org/10.3389/fphar.2023.1152611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213900/
https://www.ncbi.nlm.nih.gov/pubmed/37251320
http://dx.doi.org/10.3389/fphar.2023.1152611

Ejemplares similares